| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |